p27 Kip1 and cytoplasmic pSer10p27 are promising biomarkers for predicting prognosis and chemotherapy response in ovarian cancer

Mengna Zhu, Si Sun, Lin Huang, Lingling Gao, Mengqing Chen, Jing Cai, Zehua Wang, Minggang Peng
2023 · doi:10.21203/rs.3.rs-3195821/v1
preprint OA: closed CC-BY-4.0
📄 Open PDF View at publisher

Abstract

Purpose: The biological function of p27 Kip1 largely depends on its subcellular localization and phosphorylation status. Different subcellular localization and phosphorylation status of p27 Kip1 may represent distinct clinical values, which are not entirely clear in ovarian cancer. This study aimed to elucidate different subcellular localizations of p27 Kip1 and pSer10p27 in predicting prognosis and chemotherapy response in ovarian cancer. Methods: Meta-analyses were executed to evaluate the association of p27 Kip1 and phosphorylated p27 Kip1 with the prognosis of ovarian cancer patients. The expression levels and patterns of p27 Kip1 and pSer10p27 were evaluated by immunohistochemistry (IHC). The correlations between different p27 Kip1 states and clinicopathological features as well as prognosis were analyzed. p27 Kip1 and pSer10p27 expression level in cisplatin-sensitive and cisplatin-resistant ovarian cancer cell lines were detected using WB. KEGG analysis and WB were performed to evaluate the involved pathways of p27 Kip1 . Results: Meta-analyses showed that p27 Kip1 was associated with significantly better overall survival (OS) in ovarian cancer (HR = 2.14; 95% CI [1.71 - 2.68]) and pSer10p27 was associated with significantly poor OS in mixed solid tumors (HR = 2.56; 95% CI [1.76 - 3.73]) In our cohort of ovarian cancer patients, low total p27 Kip1 remained independent risk factors for OS (HR = 2.097; 95% CI [1.121 - 3.922], P = 0.021) and PFS (HR = 2.483; 95% CI [1.364 - 4.518], P = 0.003), while low cytoplasmic pSer10p27 had independent protective effects in terms of OS (HR = 0.472; 95% CI [0.248 - 0.898], P = 0.022) and PFS (HR = 0.488; 95% CI [0.261 - 0.910], P = 0.024). Patients with low total p27 Kip1 /pSer10p27 and low nuclear p27 Kip1 had worse chemotherapy response while patients with low cytoplasmic pSer10p27 expression had better chemotherapy response. The protein levels of p27 Kip1 and pSer10p27 were significantly reduced in cisplatin resistant cell lines SKOV3-cDDP and A2780-cDDP and the level of p27 Kip1 /pSer10p27 was subjective to Akt activation. Conclusion: The present study demonstrates that p27 Kip1 and cytoplasmic pSer10p27 are promising biomarkers for predicting prognosis and chemotherapy response in ovarian cancer.

My notes (saved in your browser only)

Citation neighborhood (sparse)

Too few in-corpus citations on either side for a chart; here are the lists.

Cites (2)

References (47)

Source provenance

crossref
last seen: 2026-09-11T06:32:26.773452+00:00
europepmc
last seen: 2026-05-19T01:45:01.086888+00:00
unpaywall
last seen: 2026-05-22T02:00:06.705733+00:00
License: CC-BY-4.0